Prostaglandin E1 therapy for digital ulcers in scleroderma.

This publication has 24 references indexed in Scilit:

• Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension.
  Heart, 1978
• PLASMAPHERESIS IN RAYNAUD'S DISEASE
  The Lancet, 1978
• INTRAVENOUS PROSTAGLANDIN E1 IN SEVERE PERIPHERAL VASCULAR DISEASE
  The Lancet, 1976
• Low molecular weight dextran therapy for scleroderma. Effects of dextran 40 on blood flow and capillary filtration coefficient in scleroderma
  Archives of Dermatology, 1974
• Low Molecular Weight Dextran Infusions in Systemic Sclerosis with Raynaud's Phenomenon: A Report of Nine Cases
  BMJ, 1970
• Intra-arterial administration of reserpine. Its use in patients with Raynaud's disease or Raynaud's phenomenon
  Archives of internal medicine (1960), 1970
• Effect of Prostaglandin E₁on Forearm Blood Flow
  Scandinavian Journal of Clinical and Laboratory Investigation, 1969
• Circulatory and Respiratory Effects of Different Doses of Prostaglandin E₁in Man
  Acta Physiologica Scandinavica, 1969
• Effects of prostaglandin E1 and adrenaline on the pulmonary vascular resistance (PVR) in isolated rabbit lungs
  Life Sciences, 1967
• Cardiovascular and Metabolic Response to Infusions of Prostaglandin E₁ and to Simultaneous Infusions of Noradrenaline and Prostaglandin E₁ in Man Prostaglandin and related factors 35
  Acta Physiologica Scandinavica, 1965